Altamira Therapeutics Ltd. (CYTO)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Altamira Therapeutics Ltd. (CYTO)
Company Performance

Current Price

as of Oct 29, 2024

$0.50

P/E Ratio

N/A

Market Cap

$1.88M

Description

Altamira Therapeutics Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. It operates through the Switzerland and Australia geographical segments. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda.

Metrics

Overview

  • HQHamilton, HA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerCYTO
  • Price$0.4987+1.30%

Trading Information

  • Market Cap$1.88M
  • Float99.47%
  • Average Daily Volume (1m)50,202
  • Average Daily Volume (3m)375,726
  • EPS-$8.76

Company

  • RevenueN/A
  • Rev Growth (1yr)-100.00%
  • Net Income-$8.09M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$6.73M
  • EV$1.09M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
  • P/B0.21
Documents